| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.32B | +3.0% |
| R&D Expense | $66.0M | -14.3% |
| SG&A Expense | $518.0M | -11.5% |
| Operating Income | $449.0M | +65.7% |
| Pre-tax Income | $139.0M | +29.9% |
| Income Tax | $47.0M | -80.3% |
| Net Income | $91.0M | +167.9% |
| EPS (Basic) | $1.26 | +166.3% |
| EPS (Diluted) | $1.23 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $419.0M | +23.6% |
| Accounts Receivable | $588.0M | -17.6% |
| Inventory | $307.0M | -7.8% |
| Current Assets | $1.77B | -6.8% |
| Total Assets | $5.55B | -3.3% |
| Current Liabilities | $1.70B | -2.6% |
| Long-term Debt | $2.99B | -3.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $344.0M | -3.1% |
| Capital Expenditures | $87.0M | -19.4% |
| Investing Cash Flow | -$135.0M | +57.3% |
| Financing Cash Flow | -$134.0M | -532.3% |
| Free Cash Flow | $257.0M | +4.0% |
| +164.7% |
| Total Liabilities |
| $5.29B |
| -3.0% |
| Stockholders' Equity | $260.0M | -8.5% |